Edward Maldonado, MD

Title(s)HS Asst Clinical Professor, Medicine
SchoolSchool of Medicine
Address1825 4th Street, #L6101
San Francisco CA 94158
PronounsHe/Him/His
ORCID ORCID Icon0000-0002-7018-8462 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Portland, Portland, OR.BS2012Biology (Minor in Chemistry)
    Creighton University School of Medicine, Omaha, NE.MD2017
    Oregon Health and Science University, Portland, OR. Internship in Internal Medicine2018
    Oregon Health and Science University, Portland, OR. Residency in Internal Medicine2020
    Oregon Health and Science University, Portland, OR. Chief Resident in Internal Medicine2021
    University of California, San Francisco, San Francisco, CA Fellowship in Hematology/Medical Oncology2024
    University of California, San Francisco, San Francisco, CA Chief Fellow in Hematology/Medical Oncology2023
    Collapse awards and honors
    University of California, San Francisco, Department of Medicine, Division of Internal Medicine2023  - 2023UCSF Internal Medicine Residency Hematology/Oncology Fellow Teaching Award
    University of California, San Francisco, Department of Medicine, Division of Hematology and Medical Oncology2022  - 2022UCSF Rachel Pearline Award: awarded to a hematology/oncology fellow who demonstrates an extraordinary commitment to patient care and embodies Rachel's deep humanism.
    Oregon Health and Science University, Department of Medicine, Division of Internal Medicine2021  - 2021OHSU Professional Board Outstanding Contribution to Education and Research
    Oregon Health and Science University, Department of Medicine, Division of Internal Medicine2020  - 2020Thomas J. & Nancy Fitzgerald Stack Award: a merit-based humanism award in recognition of integrity, dedication, and selflessness in caring for patients.
    Oregon Health and Science University, Department of Medicine, Division of Internal Medicine2020  - 2020OHSU Medical Housestaff Teaching Award
    University of Portland, Department of Biology2012  - 2012Becky Houck Award for Outstanding Teaching Assistance, Mentoring, and Service

    Collapse Overview 
    Collapse overview
    I am a Medical Oncologist within the Division of Hematology/Oncology at the University of California, San Francisco. My clinical practice focuses on care of adults with genitourinary cancers, including prostate, bladder, kidney, and testicular cancer.

    My research interests include clinical trials to evaluate promising treatments for patients with genitourinary cancers, with particular interests in advanced prostate cancer and DNA damage repair therapies. I have also participated in quality improvement projects centered around fertility preservation and medical education.

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 07 01; 4(7):1793-1801. Maldonado E, Rathmell WK, Shapiro GI, Takebe N, Rodon J, Mahalingam D, Trikalinos NA, Kalebasty AR, Parikh M, Boerner SA, Balido C, Krings G, Burns TF, Bergsland EK, Munster PN, Ashworth A, LoRusso P, Aggarwal RR. PMID: 38920407; PMCID: PMC11264598.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    2. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer. Front Oncol. 2023; 13:1161089. Jindal T, Zhu X, Bose R, Kumar V, Maldonado E, Deshmukh P, Shipp C, Feng S, Johnson MS, Angelidakis A, Kwon D, Borno HT, de Kouchkovsky I, Desai A, Aggarwal R, Fong L, Small EJ, Wong A, Porten S, Chou J, Friedlander T, Koshkin VS. PMID: 37091148; PMCID: PMC10113661.
      View in: PubMed   Mentions: 7  
    4. Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. Blood Adv. 2021 Dec 14; 5(23):5179-5189. Bond DA, Switchenko JM, Villa D, Maddocks K, Churnetski M, Gerrie AS, Goyal S, Shanmugasundaram K, Calzada O, Kolla B, Bachanova V, Gerson JN, Barta SK, Hill BT, Sawalha Y, Martin P, Maldonado E, Gordon M, Danilov AV, Grover NS, Mathews S, Burkart M, Karmali R, Ghosh N, Park SI, Epperla N, Badar T, Guo J, Hamadani M, Fenske TS, Malecek MK, Kahl BS, Flowers CR, Blum KA, Cohen JB. PMID: 34516611; PMCID: PMC9153047.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    5. Antithrombotic Therapies in COVID-19 Disease: a Systematic Review. J Gen Intern Med. 2020 Sep; 35(9):2698-2706. Maldonado E, Tao D, Mackey K. PMID: 32556875; PMCID: PMC7299557.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCellsPHPublic Health
    6. Estimation of US patients with cancer who may respond to cytotoxic chemotherapy. Future Sci OA. 2020 May 25; 6(8):FSO600. Maldonado EB, Parsons S, Chen EY, Haslam A, Prasad V. PMID: 32983564; PMCID: PMC7491026.
      View in: PubMed   Mentions: 11  
    7. Comparison of Drugs Used for Adjuvant and Metastatic Therapy of Colon, Breast, and Non-Small Cell Lung Cancers. JAMA Netw Open. 2020 04 01; 3(4):e202488. Parsons S, Maldonado EB, Prasad V. PMID: 32275321; PMCID: PMC7148439.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    8. Refractory Autoimmune Cytopenias Treated With Venetoclax. Hemasphere. 2019 Jun; 3(3):e202. Gordon MJ, Maldonado E, Danilov AV. PMID: 31723832; PMCID: PMC6746017.
      View in: PubMed   Mentions: 6  
    9. Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database Analysis. Clin Lymphoma Myeloma Leuk. 2017 Dec; 17(12):812-818. Goyal G, Maldonado EB, Fan TJ, Kanmanthareddy A, Silberstein PT, Go RS, Armitage JO. PMID: 28988670.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Edward's Networks
    Concepts (43)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.